Daiichi Sankyo Sales Reps Drop OT Suit Citing GSK Ruling

Law360, Los Angeles (July 16, 2012, 4:32 PM EDT) -- A nationwide class of pharmaceutical sales reps ended their Fair Labor Standards Act lawsuit against Daiichi Sankyo Inc. on Monday, saying the U.S. Supreme Court's decision in Christopher v. SmithKline Beecham Corp. eviscerated their federal overtime claims against the drugmaker.

“On June 18, 2012, the Supreme Court issued its decision in [GlaxoSmithKline], finding that [pharmaceutical sales reps] are outside salesmen exempt from overtime requirements under the FLSA,” the parties said in a dismissal order signed by U.S. District Judge Claire C. Cecchi on Monday. “The parties...
To view the full article, register now.